Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory.

Published byMilo Hall Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory."— Presentation transcript:

1 Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory Journal. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18(4): DOI: Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory Journal. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18(4): Allergy Asthma Immunol Res Mar;6(2):

Download ppt "Fig. 1. Relationship between the number of cigarettes smoked per day and asthma control.3 Reproduced with permission from the Primary Care Respiratory."

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Clearing the Airways: Innovation in Asthma & Allergy Treatments Chair: Alan Kaplan MD CCFP(EM) FCFP Chair, FPAGC.

Clearing the Airways: Innovation in Asthma & Allergy Treatments Chair: Alan Kaplan MD CCFP(EM) FCFP Chair, FPAGC.
Respiratory audit 318 referrals reviewed. Categories referred.

Respiratory audit 318 referrals reviewed. Categories referred.
David B. Price, FRCGP, Miguel Román-Rodríguez, MD, R

David B. Price, FRCGP, Miguel Román-Rodríguez, MD, R
Fig. 1. The distribution of serum anti-dust EV IgG concentrations in the healthy control, asthma, COPD, and lung cancer groups. The dashed vertical line.

Fig. 1. The distribution of serum anti-dust EV IgG concentrations in the healthy control, asthma, COPD, and lung cancer groups. The dashed vertical line.
Fig. 2. Comparison of the Th1/Th2 ratio and the percentages of Th1 and Th2 cells between normal and allergic individuals. (A) The Th1/Th2 ratio observed.

Fig. 2. Comparison of the Th1/Th2 ratio and the percentages of Th1 and Th2 cells between normal and allergic individuals. (A) The Th1/Th2 ratio observed.
Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted.

Fig. 3. Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted.
Fig. 2. IgE Immunoblotting analysis with pooled sera of egg-allergic patients. (A) shows an immunoblot result using native serum. (B) is a immunoblot result.

Fig. 2. IgE Immunoblotting analysis with pooled sera of egg-allergic patients. (A) shows an immunoblot result using native serum. (B) is a immunoblot result.
Figure 1. Study 1: Effect of Facebook on Self-Esteem

Figure 1. Study 1: Effect of Facebook on Self-Esteem
The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92:308-315 - DOI:10.1159/000450555.

The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92: DOI: /
Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.

Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score  Robert S. Zeiger, MD, PhD, Michael Mellon, MD, Bradley.
Defining future risk in asthma Pt. II

Defining future risk in asthma Pt. II
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy  Ana I. Tabar, MD, PhD, Esozia Arroabarren, MD, Susana.

Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy  Ana I. Tabar, MD, PhD, Esozia Arroabarren, MD, Susana.
Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 
Effect of montelukast for treatment of asthma in cigarette smokers

Effect of montelukast for treatment of asthma in cigarette smokers
Overcoming barriers to nonadherence in asthma treatment

Overcoming barriers to nonadherence in asthma treatment
Dana V. Wallace, MD, Mark S. Dykewicz, MD, David I

Dana V. Wallace, MD, Mark S. Dykewicz, MD, David I
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
J Bone Miner Res 2015;30:1553 (Fig. 1)

J Bone Miner Res 2015;30:1553 (Fig. 1)

Similar presentations

Ads by Google